Literature DB >> 9669150

The science and therapy of glucocorticoid-induced bone loss.

N E Lane1, B Lukert.   

Abstract

Glucocorticoids are critical in the management of chronic, noninfectious, inflammatory diseases. Bone loss is a most devastating side effect of these powerful medications. Glucocorticoids produce bone loss by altering calcium metabolism, suppressing gonadal hormone production, and inhibiting bone formation. Now that the mechanism of glucocorticoid-induced bone loss is understood and effective medications are available, this disease can be prevented and reversed.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9669150     DOI： 10.1016/s0889-8529(05)70017-7

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  30 in total

1.  Corticosteroid injections for osteoarthritis of the knee: meta-analysis.

Authors:  Bruce Arroll; Felicity Goodyear-Smith
Journal:  BMJ       Date:  2004-03-23

Review 2.  Mineral and Bone Disease in Kidney Transplant Recipients.

Authors:  Ariella M Altman; Stuart M Sprague
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

3.  Bone mineral density before and after surgical cure of Cushing's syndrome due to adrenocortical adenoma: prospective study.

Authors:  Akiko Kawamata; Masatoshi Iihara; Takahiro Okamoto; Takao Obara
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

Review 4.  Glucocorticoid-induced osteoporosis.

Authors:  Stuart L Silverman; Nancy E Lane
Journal:  Curr Osteoporos Rep       Date:  2009-03       Impact factor: 5.096

5.  Potent antiarthritic properties of a glucocorticoid derivative, NCX-1015, in an experimental model of arthritis.

Authors:  Mark J Paul-Clark; Lucia Mancini; Piero Del Soldato; Roderick J Flower; Mauro Perretti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 6.  Corticosteroid-induced adverse events in adults: frequency, screening and prevention.

Authors:  Laurence Fardet; Abdulrhaman Kassar; Jean Cabane; Antoine Flahault
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

7.  Glucocorticoids suppress bone formation via the osteoclast.

Authors:  Hyun-Ju Kim; Haibo Zhao; Hideki Kitaura; Sandip Bhattacharyya; Judson A Brewer; Louis J Muglia; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

8.  Skeletal effects of short-term exposure to dexamethasone and response to risedronate treatment studied in vivo in rabbits by magnetic resonance micro-imaging and spectroscopy.

Authors:  Masaya Takahashi; Punam K Saha; Felix W Wehrli
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

9.  Quantitative ultrasound and bone mineral density: discriminatory ability in patients with rheumatoid arthritis and controls with and without vertebral deformities.

Authors:  R E Ørstavik; G Haugeberg; T Uhlig; P Mowinckel; T K Kvien; J A Falch; J I Halse
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

Review 10.  Long-term therapy in COPD: any evidence of adverse effect on bone?

Authors:  Arnulf Langhammer; Siri Forsmo; Unni Syversen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.